EUVIMEDEUVIMED entdecken
Crossref

Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma

Ying Hou, Yipeng Tang, Chi Ma, Jingbo Yu, Youpeng Jia

Digestive and Liver Disease · 2023

DOI: 10.1016/j.dld.2022.12.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2023. Verfasst von Ying Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Blood Transfusion Department, Dalian Municipal Central Hospital, Dalian, Liaoning 116033, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Long non-coding RNAs (lncRNAs) have been implicated as functional molecules in hepatocellular carcinoma (HCC) progression. The present research aimed to investigate the levels of LncRNA cancer susceptibility candidate gene 19 (CASC19) in HCC tissues and cell lines and to explore its potential role in the diagnosis and prognosis of HCC. METHODS: HCC tissues and cell lines were collected to assess the levels of CASC19 by real-time quantitative reverse transcription PCR (RT-qPCR). The prognostic value of CASC19 was evaluated using the Kaplan-Meier method and Cox regression analysis. The functional role of CASC19 in regulating HCC cell proliferation, migration, and invasion was evaluated by Cell Counting Kit-8 (CCK-8) and Transwell analysis. The potential targeted miR-140-5p of CASC19 was confirmed by a dual-luciferase reporter assay. RESULTS: High CASC19 expression positively correlated with tumor size, differentiation, and TNM stage in HCC patients (P < 0.05). Patients with high CASC19 expression have a poorer survival prognosis and are prone to relapse compared to those with low CASC19. miR-140-5p, a target miRNA for CASC19, negatively correlated with CASC19 levels in tumor tissues. Reduced CASC19 levels attenuated cell proliferation, migration, and invasion, but this attenuation was reversed by suppression of miR-140-5p. CONCLUSION: Up-regulated CASC19 may serve as a biomarker for predicting poor prognosis in HCC patients. In vitro, overexpressed CASC19 promoted the progression of HCC, indicating that CASC19 may be a possible therapeutic target for the treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsRNA, Long NoncodingHumansCell Line, TumorNeoplasm Recurrence, LocalPrognosisCell ProliferationCell MovementGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CASC19HCCLong non-coding RNAsPrognosis

Substanzen

MicroRNAsRNA, Long NoncodingMirn140 microRNA, human

Autor:innen und Institutionen

  • Blood Transfusion Department, Dalian Municipal Central Hospital, Dalian, Liaoning 116033, China.
  • Hepatobiliary Surgery Department, Dalian Municipal Central Hospital, No. 826 Southwest Road, Dalian, Liaoning 116033, China.
  • Hepatobiliary Surgery Department, Dalian Municipal Central Hospital, No. 826 Southwest Road, Dalian, Liaoning 116033, China. Electronic address: jiayp_dlzxyy@yeah.net.

Zitieren

APA

Hou, Y., Tang, Y., Ma, C., Yu, J., & Jia, Y. (2023). Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2022.12.001

Vancouver

Hou Y, Tang Y, Ma C, Yu J, Jia Y. Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma. Digestive and Liver Disease. 2023. doi:10.1016/j.dld.2022.12.001

BibTeX
@article{Hou2023,
  author = {Hou, Ying and Tang, Yipeng and Ma, Chi and Yu, Jingbo and Jia, Youpeng},
  title = {Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma},
  journal = {Digestive and Liver Disease},
  year = {2023},
  doi = {10.1016/j.dld.2022.12.001}
}
Kostenlos starten →